Sector: Computer and TechnologyPhase Forward Incorporated (NASDAQ: PFWD)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Computer and Technology |
Funamental : | 647 |
Technical : | 141 |
Performance : | 110 |
Overall: | 240 |
Number of Stocks: | 762 |
Scan Date: | 11/3/2009 |
Sector: | Computer and Technology |
Funamental : | 554 |
Technical : | 407 |
Performance : | 280 |
Overall: | 466 |
Number of Stocks: | 763 |
Scan Date: | 10/27/2009 |
Sector: | Computer and Technology |
Funamental : | 594 |
Technical : | 173 |
Performance : | 330 |
Overall: | 352 |
Number of Stocks: | 762 |
Headlines
- Phase Forward CFO Chris Menard to Present at 2009 MIT Sloan CFO Summit
Nov 16, 2009 09:00 AM | PFWD
- Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council
Nov 06, 2009 01:00 PM | PFWD
- Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm(TM) Electronic Data Capture Solution
Nov 05, 2009 03:00 AM | PFWD
- Phase Forward Announces Share Repurchase Program
Nov 04, 2009 12:00 PM | PFWD
- Phase Forward to Present at the 18th Annual Credit Suisse Healthcare Conference
Nov 04, 2009 08:31 AM | PFWD
- Phase Forward Teams with PharmaNet Development Group
Nov 04, 2009 03:00 AM | PFWD
- Phase Forward to Participate in Six Industry Events in November
Nov 03, 2009 09:00 AM | PFWD
- Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston
Nov 02, 2009 09:01 AM | BMY, FOLD, GENZ, PFWD
- Phase Forward Announces FDA Contract Award for Production Rollout of WebSDM(TM) with Empirica(TM) Study
Nov 02, 2009 09:00 AM | PFWD
- Bausch & Lomb Automates Clinical Trial Management with Phase Forward InForm(TM)
Oct 29, 2009 09:04 AM | PFWD
- Phase Forward Reports Third Quarter 2009 Results
Oct 29, 2009 04:56 PM | AGN, AZN, CVD, LLY, PFWD, PG
- Phase Forward to Present at the 11th Annual Pacific Crest Technology Leadership Forum
Aug 04, 2009 04:20 PM | PFWD
- Phase Forward Named to FORTUNE Small Business 100 List of Fastest-Growing Public Companies
Jul 30, 2009 09:15 AM | PFWD
- APCER Pharma Solutions, Inc. Appoints Senior Bio-Pharmaceutical Industry Executives Susan A. Jalbert and Ronald M. Lillie to U.S. Management Team
Jul 28, 2009 12:33 PM | PFWD
- Phase Forward Reports Second Quarter 2009 Results
Jul 27, 2009 05:01 PM | AZN, CVD, LLY, PFWD, PG
- Phase Forward Acquires Maaguzi LLC, Innovative Provider of Web-Based Electronic Patient Reported Outcomes (ePRO) and Late Phase Solutions
Jul 27, 2009 04:20 PM | PFWD
- CORRECTING and REPLACING Phase Forward Agrees to Acquire Covance’s Interactive Voice and Web Response Services Business
Jul 15, 2009 12:06 PM | PFWD
- Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
Jul 15, 2009 09:47 AM | CVD, PFWD
- Phase Forward Agrees to Acquire Covance’s Interactive Voice and Web Response Services Business
Jul 15, 2009 09:41 AM | PFWD
- Phase Forward CEO Bob Weiler Presides Over NASDAQ Stock Market Opening Bell, Commemorates Company's Five Year Listing Anniversary
Jul 14, 2009 12:14 PM | PFWD
- Form 4 Phase Forward Inc For: Nov 16 Filed by: Powell Stephen John (10K)
Nov 18, 2009 04:51 PM
- Form 4 Owings Michael Paul For: Aug 21 (10K)
Aug 25, 2009 05:39 PM
- Form 4 Owings Michael Paul For: Jul 30 (10K)
Aug 03, 2009 07:03 PM
- Form 4 Weiler Robert K For: Jun 17 (10K)
Jun 19, 2009 06:01 PM
- Form 4 Russell Channing Heard For: Jun 08 (10K)
Jun 10, 2009 07:56 PM
- Form 4 Rosenberg Steven J For: Jun 08 (10K)
Jun 10, 2009 07:56 PM
- Form 4 Powell Stephen John For: Jun 08 (10K)
Jun 10, 2009 07:56 PM
- Form 4 Owings Michael Paul For: Jun 08 (10K)
Jun 10, 2009 07:56 PM
- Form 4 Menard Christopher For: Jun 08 (10K)
Jun 10, 2009 07:56 PM
- Form 4 Buchler D Ari For: Jun 08 (10K)
Jun 10, 2009 07:56 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
PFWD
|
Compare to S&P
|
| YTD |
25.56 %
|
3.72 %
|
| 4 Weeks |
13.58 %
|
12.98 %
|
| 12 Weeks |
13.18 %
|
6.20 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -25.00 %
|
|
EPS Growth in Last Year: -25.00 %
|
|
Sales Growth in Last Quarter: 2.05 %
|
|
Sales Growth in Last Quarter: 23.56 %
|
|
